Literature DB >> 2885451

Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.

S E Humphries, M Cook, M Dubowitz, Y Stirling, T W Meade.   

Abstract

Three restriction fragment length polymorphisms (RFLPs) of the fibrinogen genes were used in 91 individuals to investigate the role of genetic variation at this locus in the determination of plasma fibrinogen. The strongest association was with a polymorphism detected with the beta-fibrinogen probe and the enzyme BclI. The probe detects two alleles, designated B1 and B2. The individuals with the genotype B1B1 had a mean fibrinogen of 2.74 g/l; those with B2B2 had a mean fibrinogen of 3.69 g/l (a level previously associated with a strongly increased risk of ischaemic heart disease); and those heterozygous for the two alleles, with the genotype B1B2, had a mean of 2.98 g/l. Genetic variation at the fibrinogen gene locus accounted for 15% of the total phenotypic variance in fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885451     DOI: 10.1016/s0140-6736(87)92205-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

1.  Risk factors for thromboembolism: pathophysiology and detection.

Authors:  S Solymoss
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

2.  Genetic variation at fibrinogen loci and plasma fibrinogen levels.

Authors:  J M Connor; F G Fowkes; J Wood; F B Smith; P T Donnan; G D Lowe
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

Review 3.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

4.  The association between thrombophilic gene mutations and recurrent pregnancy loss.

Authors:  Ahmad Poursadegh Zonouzi; Nader Chaparzadeh; Saeid Ghorbian; Mahzad Mehrzad Sadaghiani; Laya Farzadi; Alieh Ghasemzadeh; Taiebeh Kafshdooz; Masoud Sakhinia; Ebrahim Sakhinia
Journal:  J Assist Reprod Genet       Date:  2013-08-29       Impact factor: 3.412

Review 5.  Drugs affecting plasma fibrinogen levels.

Authors:  G di Minno; M Mancini
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

6.  Fibrinogen and cardiovascular disease.

Authors:  T W Meade
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

Review 7.  Molecular genetics of common diseases.

Authors:  J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

Review 8.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

9.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Authors:  A J Lee; G D Lowe; M Woodward; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1993-04

10.  Frequency distribution of the G/A alleles of the beta-fibrinogen gene in the Lebanese population.

Authors:  Dina M R Shammaa; Amira S Sabbagh; Ali T Taher; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-05-12       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.